Article

VIDEO: Dr. Robert Margolis Discusses Population-Based Healthcare

Conference|AHIP Institute & Expo

Robert Margolis, MD, Managing Partner and CEO, HealthCare Partners, states that physicians and hospitals need to understand how to assess health and insurance risks in order to provide better care.

Robert Margolis, MD, Managing Partner and CEO, HealthCare Partners, states that physicians and hospitals need to understand how to assess health and insurance risks in order to provide better care. Without information and technology systems there is not enough information to make good decisions for specific patient populations.

This video interview was performed on June 21, 2012, at the America's Health Insurance Plans Institute 2012 in Salt Lake City, UT.

Related Videos
Steven Daniel Daveluy, MD, FAAD
Dr Toon Van Gorp
Annie Antar, MD, PhD, Johns Hopkins Medicine
Leigh Maria Ramos-Platt, MD
Michelle Hessen, OD
Annie Antar, MD, PhD, Johns Hopkins Medicine
Barry Byrne, MD
Giulio Cossu, MD
Dr Toon Van Gorp
Related Content
Crystal Aguh, MD, FAAD
March 26th 2025

Dermatologists Advocating for Inclusive Hair Loss Research and Treatment in the African Diaspora

Cameron Santoro Crystal Aguh, MD, FAAD
Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, advocates for increased funding and education to address hair loss disparities within the African diaspora, emphasizing the need for culturally sensitive treatment and research.
managed care cast logo
December 5th 2024

Advancing Women's Health: CVS Health Leader on Access, Technology, and Breaking Stigmas

Brooke McCormick
On this episode of Managed Care Cast, we speak with CVS Health's vice president and chief medical officer for women's health and genomics about advancements and challenges in women's health, focusing on care access, technology, and maternal outcomes.
Woman affected by blurry vision | Image Credit: Prostock-studio - stock.adobe.com
March 25th 2025

Ocular Adverse Events From Mirvetuximab Soravtansine Not Associated With HRQoL Impact in FRα+ Ovarian Cancer

Brooke McCormick
New phase 3 data provide reassurance on safety, tolerability, and overall benefit-risk of mirvetuximab soravtansine (Elahere) for patients with folate receptor alpha-positive (FRα+), platinum-resistant ovarian cancer.
Managed Care Cast logo
September 16th 2024

Healing Wounds Through Peer Support

Maggie L. Shaw
September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In this third episode, we speak with Kim MacDonald-Wilson, ScD, CPRP, and Tracy Carney, CPS, CPRP.
MDA logo | image credit: mda.org
March 24th 2025

Building Community and Advancing Care at MDA 2025

Kyle Munz Sharon Hesterlee, PhD Tania Gendron, PhD Guilio Cossu, MD Barry Byrne, MD, PhD Leigh Maria Ramos-Platt, MD
One of the major highlights of the Muscular Dystrophy Association (MDA) Clinical & Scientific Conference is that invaluable networking opportunities can help clinicians elevate their own best practices.
MDA celebrates its 75th anniversary | Image Credit: Christina Mattina
March 24th 2025

MDA Reflects on 75 Years of Research and the Precarious Times Ahead

Christina Mattina
Speakers from the Muscular Dystrophy Association (MDA) highlighted 75 years of progress in understanding and treating neuromuscular diseases but also raised concerns about how potential funding cuts could impact this community.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo